Loading...
Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease
Ceftriaxone is a beta-lactam antibiotic that increases the expression of the major glutamate transporter, GLT-1. As such, ceftriaxone ameliorates symptoms across multiple rodent models of neurological diseases and substance use disorders. However, the mechanism behind GLT-1 upregulation is unknown....
Saved in:
| Published in: | Neurosci Biobehav Rev |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7483567/ https://ncbi.nlm.nih.gov/pubmed/32485268 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neubiorev.2020.05.016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|